Results 191 to 200 of about 16,258 (219)

PON1 lactonase activity and its association with cardiovascular disease.

Clinica chimica acta; international journal of clinical chemistry, 2019
BACKGROUND Paraoxonase 1 (PON1) is important in the development of atherosclerosis, and it has become the subject of intensive research. Our aim was to evaluate the association of serum PON1 activity and polymorphisms with cardiovascular disease (CVD ...
F. E. Murillo-González, N. Ponce-Ruíz, A. Rojas-García, S. Rothenberg, Y. Y. Bernal-Hernández, R. Cerda-Flores, M. Mackness, B. Barrón-Vivanco, C. A. González-Arias, Jaime Ponce-Gallegos, Irma Martha Medina-Díaz   +10 more
semanticscholar   +1 more source

Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease.

Clinical Biochemistry, 2018
INTRODUCTION Cardiovascular complications, as the main cause of mortality in renal patients, are followed with altered lipoproteins composition. Considering that paraoxonase-1 (PON1) is an anti-oxidative enzyme located mainly on HDL particles, the ...
M. Miljkovic, A. Stefanović, J. Vekić, A. Zeljković, T. Gojković, S. Simić-Ogrizović, N. Bogavac-Stanojević, Darko Cerne, J. Ilić, I. Štefanović, Z. Jelić-Ivanović, V. Spasojević-Kalimanovska, J. Kotur-Stevuljević   +12 more
semanticscholar   +1 more source

Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes.

Clinica chimica acta; international journal of clinical chemistry, 2018
OBJECTIVE Genome studies have shown that the genes encoding paraoxonase 1 (PON1) and PON2 are associated with glucose metabolism. The goal of this study was to simultaneously evaluate the association between functional variants in PON1 and PON2 genes and
A. Mahrooz, M. Hashemi-Soteh, Masoud Heydari, Ruzbeh Boorank, F. Ramazani, Ali Mahmoudi, Anvarsadat Kianmehr, A. Alizadeh   +7 more
semanticscholar   +1 more source

Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis.

Journal of Stroke & Cerebrovascular Diseases, 2017
L. Wei, A. Au, Saras Menon, L. Griffiths, Cheah Wee Kooi, L. Irene, Jiangyang Zhao, Chaeyoung Lee, Avdonina Maria Alekseevna, M. Hassan, Z. A. Aziz   +10 more
semanticscholar   +1 more source

Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells

Environmental Toxicology, 2017
I. Medina-Díaz, N. Ponce-Ruíz, Bryana Ramírez-Chávez, A. Rojas-García, B. Barrón-Vivanco, G. Elizondo, Y. Y. Bernal-Hernández   +6 more
semanticscholar   +1 more source

Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?

Clinical Rheumatology, 2017
Cemil Ertürk, M. Altay, A. Bilge, H. Çelik   +3 more
semanticscholar   +1 more source

Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.

Clinical Biochemistry, 2017
A. Tajbakhsh, M. Rezaee, M. Rivandi, F. Forouzanfar, F. Afzaljavan, A. Pasdar   +5 more
semanticscholar   +1 more source

Paraoxonase (PON1) Deficiency Is Associated With Increased Macrophage Oxidative Stress: Studies in PON1-Knockout Mice

Free Radical Biology and Medicine, 2003
Diana M Shih, Mira Rosenblat, Raymond Coleman   +2 more
exaly  

Effect of the Molecular Polymorphisms of Human Paraoxonase (PON1) on the Rate of Hydrolysis of Paraoxon

British Journal of Pharmacology, 1997
Paul Durrington, Bharti Mackness, Sharon Arrol   +2 more
exaly  

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.

Current Clinical Pharmacology, 2016
A. Mahrooz
semanticscholar   +1 more source